Best Life Sciences Tech Companies in Singapore
The 40 best Life Sciences Tech companies in Singapore in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Engine Biosciences.
- LifeSciencesIntelligence
- EVERSANA
Our analysis of 50 Life Sciences Tech companies
$9.6b in tracked funding; 89% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Tech companies in Singapore
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Engine Biosciences Developer of platform technology for combinatorial genetics discovery | $86M | 34 mo ago | Series A | Jeffrey Lu Co-Founder And Ceo | 2014 | WordPressMySQLPHP+20 | — |
| 2 | NSG BioLabs Operator of shared BSL-2 laboratory and office spaces for life science | $14M | 27 mo ago | Series B | Daphne Teo Founder & CEO | 2019 | WordPressMySQLPHP+22 | 1 partnership |
| 3 | Gero Developer of reverse engineering technology for controlling aging | $14M | 34 mo ago | Series A | Peter Fedichev Co-founder & CEO | 2015 | TildaGoogle Font APIYandex.Metrika+7 | — |
| 4 | Qritive AI-based oncology diagnostic solution based on microscopic images & patient data | $8M | 43 mo ago | Series A | Kavita Butalia Co-Founder | 2017 | WixSentryYouTube+20 | 1 partnership |
| 5 | HistoIndex Provider of AI powered digital pathology platform for fibrosis analysis | $7M | 16 mo ago | Series A | Dean Tai Co-Founder & Chief Scientific Officer | 2010 | WordPressMySQLPHP+26 | — |
| 6 | KYAN Technologies Provider of personalized medical solution, drug screening, and computational analysis services | $5M | 46 mo ago | Seed | Hugo Saavedra Co Founder | 2022 | WordPressMySQLPHP+24 | — |
| 7 | Choir CRM Provider of cloud-based CRM software for life sciences companies | $2M | 35 mo ago | Seed | Henry Sun Co-Founder | 2022 | — | — |
| 8 | Craft Health Provider of 3D printed personalized pharmaceuticals and nutraceuticals with end-to-end solutions | $1M | 27 mo ago | Series A | Wei Goh Co-Founder & CEO | 2019 | — | — |
Top 12 Life Sciences Tech companies in Singapore
#1
Series A · Singapore, Singapore · founded 2010 · 20 employees$6.9Mraised▾
Provider of AI powered digital pathology platform for fibrosis analysis. The platform utilizes Second Harmonic Generation (SHG) and Two-Photon Excitation (TPE) microscopy to capture high-resolution images of unstained tissue samples to quantify fibrosis and other morphological features. The technology accelerates therapeutic development and clinical trial by providing translatable data from preclinical studies to clinical trials and enhancing clinical diagnostics. It supports advancements and regulatory approvals across the drug development and clinical diagnostic value chain.
- May 2025Series A$6.9M
- Jun 2013Seed—
#2
Series A · Singapore, Singapore · founded 2014 · 39 employees$86Mraised▾
Developer of platform technology for combinatorial genetics discovery. The company's platform technology for the discovery of novel gene and drug combinations for therapeutic and industrial biotechnology applications. The company's technology allows for ultra-high-throughput screens and the discovery of combinatorial genes and drugs with effects on targeted phenotypes.
- Oct 2023Series A$27M
- May 2021Series A$43M
- Jan 2018Seed$10M
#3
Series B · Singapore, Singapore · founded 2019 · 6 employees$14.5Mraised▾
Operator of shared BSL-2 laboratory and office spaces for life science. The company provides fully equipped facilities designed for research and development. It offers specialized spaces optimized for tissue culture and microbiological work. The company supports researchers with comprehensive amenities and equipment to facilitate scientific advancements.
- May 2024Series B$14.5M
#4
Series A · Singapore, Singapore · founded 2015 · 39 employees$13.5Mraised▾
Gero is a developer of reverse engineering technology for controlling aging. It is a biotech company focusing on the data analytics of biobanks and large medical studies. The company uses dynamical systems theory and physics of complex systems for analytics and provides predictive models for discovering biomarkers of aging. The analytics can be used to create therapies to control the aging process.
- Oct 2023Series A$6M
- Aug 2020Series A$2.2M
- May 2019Seed—
#5
Series A · Singapore, Singapore · founded 2017 · 31 employees$7.5Mraised▾
AI-based oncology diagnostic solution based on microscopic images & patient data. The company also claims that the solutions will help healthcare providers reduce costs associated with cancer diagnoses.
- Jan 2023Series A$7.5M
- Seed—
#6
Series A · Singapore, Singapore · founded 2019 · 9 employees$1Mraised▾
Provider of 3D printed personalized pharmaceuticals and nutraceuticals with end-to-end solutions. It offers customized approaches to drug delivery, from research and development to manufacturing. The company provides hardware, software, and formulation integration for mass customization. Varied dosage forms such as tablets, beads, and gummies are manufactured in a HEPA filtered clean environment, from prototyping to pilot batch.
- May 2024Series A—
- Seed$1M
#7
Seed · Singapore, Singapore · founded 2022$2Mraised▾
Provider of cloud-based CRM software for life sciences companies. It offers life science solutions to help companies with customer relationship management, quality data management and commercial artificial inteligence. It is designed for life sciences, focusing on managing patient relationships and enhancing patient outcomes.
- Sep 2023Seed$2M
#8
Seed · Singapore, Singapore · founded 2022 · 6 employees$5Mraised▾
Provider of personalized medical solution, drug screening, and computational analysis services
- Oct 2022Seed$5M
#9
Deadpooled · Singapore, Singapore · founded 2018 · 1 employees$55Kraised▾
Gallenco offers an online platform for managing manual medical laboratory workflows. The software uses digital microscopy and artificial intelligence technology to provide workflow management solutions.
- Jan 2019Seed$55K
#10
Seed · Singapore, Singapore · founded 2023—raised▾
AI-powered platform automating daily workflows for scientific, clinical, and commercial scenarios. It enables life science professionals transforming complexity into actionable insight with AI built for the realities of life sciences.
- Dec 2025Seed—
- Feb 2025Seed—
#11
Seed · Singapore, Singapore · founded 2020 · 14 employees—raised▾
AI-based drug discovery and clinical data analysis solutions for researchers
- Oct 2025Seed—
#12
Seed · Singapore, Singapore · founded 2019—raised▾
Provider of technology and services for clinical trials in healthcare. The company offers a customizable technology platform designed for use in clinical settings. This platform supports pharma, biotech, medical device, and digital health research. It aims to accelerate healthcare innovation by streamlining clinical trial processes.
- Mar 2025Seed—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Tech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Singapore
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 281 Singapore-affiliated papers.
- Ministry of Education70
- National University of Singapore38
- Nanyang Technological University35
- Agency for Science, Technology and Research25
- Ministry of Health25
- In vivo10
- Gene7
- Messenger RNA6
- Immune system5
- Cell biology4
- Bacteria7
- In vivo5
- Yield (engineering)4
- Synthetic biology4
- Gene4
- In vivo4
- Production (economics)4
- Disease3
- Human health3
- Antibiotic resistance2
Where biotechnology is researched across Singapore
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.